Skip to main content

Advertisement

ADVERTISEMENT

Pulmonary Arterial Hypertension News

News
03/16/2015

Mary Beth Nierengarten

Mary Beth Nierengarten
Results of a budgetary impact model study showed that the addition of riociguat to treat patients with PAH or CTEPH offers US health plans an additional treatment for these conditions that is safe, effective, and associated with minimal...
Results of a budgetary impact model study showed that the addition of riociguat to treat patients with PAH or CTEPH offers US health plans an additional treatment for these conditions that is safe, effective, and associated with minimal...
Results of a budgetary impact...
03/16/2015
First Report Managed Care

Advertisement